What are the minimum age and weight requirements for adolescents receiving Tybost (cobicistat) with atazanavir or darunavir for HIV-1 infection?

For HIV-1 infection, adolescents receiving Tybost (cobicistat) as part of antiretroviral combination therapy must be at least 12 years old and weigh at least 35 kg with atazanavir 300 mg once daily or at least 40 kg with darunavir 800 mg once daily.